Lorenz Trümper
Impact in
- Pathology and Forensic Medicine top 0.1%
- Lymphoma Diagnosis and Treatment
- Genetics top 0.2%
- Chronic Lymphocytic Leukemia Research
Papers in
-
- Lymphoma Diagnosis and Treatment 121
- Genetics 62
- Chronic Lymphocytic Leukemia Research 52
- Co-authors
- Michael PfreundschuhMarkus LoefflerMarita ZiepertClaudia R. BinderNorbert SchmitzAndreas RosenwaldGerald WulfTobias Pukrop
- Journals
- Blood (20 papers)Journal of Clinical Oncology (18 papers)Annals of Oncology (15 papers)Annals of Hematology (13 papers)British Journal of Haematology (6 papers)
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Lorenz Trümper
198 papers receiving 7.4k citations
Hit Papers
Peers
Comparison fields: 5 of 126
- Pathology and Forensic Medicine 3.9k
- Genetics 2.1k
- Oncology 3.3k
- Hematology 1.0k
- Immunology 1.6k
Countries citing papers authored by Lorenz Trümper
This map shows the geographic impact of Lorenz Trümper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lorenz Trümper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lorenz Trümper more than expected).
Fields of papers citing papers by Lorenz Trümper
This network shows the impact of papers produced by Lorenz Trümper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lorenz Trümper. The network helps show where Lorenz Trümper may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lorenz Trümper, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2023 | 2 | |
| 4 | 2022 | 16 | |
| 5 | 2021 | 2 | |
| 6 | 2021 | 14 | |
| 7 | 2017 | 37 | |
| 8 | 2014 | 5 | |
| 9 | 2014 | 48 | |
| 10 | 2013 | 29 | |
| 11 | 2012 | 32 | |
| 12 | 2010 | 377 | |
| 13 | 2010 | 101 | |
| 14 | 2009 | 303 | |
| 15 | 2008 | 3 | |
| 16 | 2008 | 37 | |
| 17 | 2008 | 16 | |
| 18 | [Mesenchymal stem cells from bone marrow. Phenotype, aspects of biology, and clinical perspectives]. | 2006 | 17 |
| 19 | Efficacy of subcutaneous Alemtuzumab (Campath-1H) in genetic high-risk, fludarabine-refractory CLL: CLL2H study of the German CLL Study Group (GCLLSG) | 2005 | 18 |
| 20 | 1994 | 10 |
About Lorenz Trümper
Lorenz Trümper is a scholar working on Pathology and Forensic Medicine, Genetics, Oncology, Hematology and Immunology, having authored 203 papers that have together received 7.5k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (121 papers), Chronic Lymphocytic Leukemia Research (52 papers), CAR-T cell therapy research (29 papers), Viral-associated cancers and disorders (27 papers), Immune Cell Function and Interaction (21 papers), Acute Lymphoblastic Leukemia research (17 papers), Acute Myeloid Leukemia Research (16 papers) and Lung Cancer Treatments and Mutations (15 papers). The work is most often cited by research in Pathology and Forensic Medicine (3.9k citations), Genetics (2.1k citations), Oncology (3.3k citations), Hematology (1.0k citations) and Immunology (1.6k citations). Lorenz Trümper has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Michael Pfreundschuh, Markus Loeffler, Marita Ziepert, Claudia R. Binder, Norbert Schmitz, Andreas Rosenwald, Gerald Wulf, Tobias Pukrop, Wolfram Klapper and Peter Mӧller. Their work appears in journals such as Blood, Journal of Clinical Oncology, Annals of Oncology, Annals of Hematology and British Journal of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.